Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iodine-131 Anti-B1 Antibody for Rituximab-Pretreated NHL
NCT00996593Phase 2Completed
- Sponsor
- GSK
- Start
- Jul 1998
- Primary completion
- Apr 2001
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of tositumomab in non-Hodgkin lymphoma (NHL), sponsored by GSK. Started Jul 1998; status: completed.
02
Drugs
tositumomab
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00996593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00996593.